Author Archives: Stephen B. Hanauer, Gary R. Lichtenstein, J-F. Columbel, Lloyd Mayer, Stephan Schreiber, Daniel Rachmilewicz, Doug Wolf, Helmut Malchow, Michael Safdi, Brian Feagan, Allan Olson, Paul Rutgeerts

Maintenance infliximab (Remicade) is safe, effective and steroid-sparing in Crohn’s disease: Preliminary results from the accent i trial

Posted on July 15, 2015 by Stephen B. Hanauer, Gary R. Lichtenstein, J-F. Columbel, Lloyd Mayer, Stephan Schreiber, Daniel Rachmilewicz, Doug Wolf, Helmut Malchow, Michael Safdi, Brian Feagan, Allan Olson, Paul Rutgeerts
Comments Off on Maintenance infliximab (Remicade) is safe, effective and steroid-sparing in Crohn’s disease: Preliminary results from the accent i trial